We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
Avoid tobacco use and moderate alcohol consumption.
Even though taking acetylsalicylic acid and non-steroidal anti-inflammatory agents reduces the risk of developing colorectal cancer, the adverse cardiovascular, gastrointestinal and renal effects means the systematic use of these drugs to prevent colorectal cancer is not recommended.
Secondary prevention or screening aims to detect the cancer or polyps in an early stage, before the symptoms start to appear (blood in stools, constipation, diarrhoea, anaemia, etc.). The purpose of screening tests is to prevent the appearance of colorectal cancer (by removing the precursory lesions or polyps before they degenerate into cancer) and to reduce the death rate associated with it (as the earlier the colorectal cancer is detected, then the greater the chances of being cured).
Screening strategies vary in function of each person’s risk of developing colorectal cancer:
Population with a medium level of risk are individuals aged ≥ 50 and who present no other risk factors associated with colorectal cancer (neither any personal medical history of this cancer or polyps, nor any family history of colorectal cancer). Members of this group (men and women aged 50–69 years) are advised to participate, every 2 years, in the colorectal cancer population screening programme which works by detecting faecal occult blood (FOB). The FOB test detects invisible traces of blood in stools, which can indicate the presence of a polyp or colorectal cancer; if blood is detected, then the patient should undergo a colonoscopy.
A family history including relatives who have suffered colorectal cancer increases an individual’s risk of developing the disease. In such cases the most appropriate screening test is a colonoscopy, while the age to initiate screening and the frequency of tests depend on the number of effected relatives, their ages at diagnosis and the degree of kinship.
People with a family history of hereditary colorectal cancers (e.g., Lynch syndrome or familial adenomatous polyposis) have a high risk of developing colorectal cancer. Screening through colonoscopies performed in special units is recommended for these cases.
Tertiary prevention or surveillance in patients who have already suffered polyps or colorectal cancer aims to avert the consequences associated with the development of these lesions. This group of patients should therefore receive colonoscopic surveillance to detect if the cancer reappears or any new polyps as early as possible.
Antonio Maria Lacy FortunyGeneral and Digestive SurgeryGastrointestinal Surgery Department
Estela Pineda LosadaOncologyMedical Oncology Department
Francesc Balaguer PrunesGastroenterologistGastroenterology Department
Mª Rosa Costa QuintàsNurseGastrointestinal Surgery Department
Published: 20 February 2018
Updated: 20 February 2018
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.
Receive the latest updates related to this content.
Thank you for subscribing!
If this is the first time you subscribe you will receive a confirmation email, check your inbox
An error occurred and we were unable to send your data, please try again later.